Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9519762rdf:typepubmed:Citationlld:pubmed
pubmed-article:9519762lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0001455lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0001492lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:9519762lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:9519762pubmed:issue3lld:pubmed
pubmed-article:9519762pubmed:dateCreated1998-4-7lld:pubmed
pubmed-article:9519762pubmed:abstractTextGlucose-induced insulin release is decreased in the spontaneously diabetic GK rat, a nonobese rodent model of type 2 diabetes. Forskolin restores the impaired insulin release in both the isolated perfused pancreas and isolated islets from these rats (Abdel-Halim et al., Diabetes 45:934-940, 1996). We demonstrate here that the insulinotropic effect of forskolin in the GK rat is due to increased generation of cAMP and that it is associated with overexpression of adenylyl cyclase (AC)-III mRNA and gene mutations. The AC-III mRNA overexpression was demonstrated by in situ hybridization using oligonucleotide probes binding to different regions of the rat AC-III mRNA. It was associated with the presence of two point mutations identified at positions -28 bp (A --> G) and -358 bp (A --> C) of the promoter region of the AC-III gene and was demonstrable in both GK rat islets and peripheral blood cells. Transfection of COS cells with a luciferase reporter gene system revealed up to 25-fold increased promoter activity of GK AC-III promoter when compared with normal rat promoter (P < 0.0001). In conclusion, forskolin restores the impaired insulin release in islets of the GK rat through enhanced cAMP generation. This is linked to overexpression of AC-III mRNA in GK islets due to two functional point mutations in the promoter region of the AC-III gene.lld:pubmed
pubmed-article:9519762pubmed:languageenglld:pubmed
pubmed-article:9519762pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9519762pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9519762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9519762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9519762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9519762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9519762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9519762pubmed:statusMEDLINElld:pubmed
pubmed-article:9519762pubmed:monthMarlld:pubmed
pubmed-article:9519762pubmed:issn0012-1797lld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:HöjebergBBlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:Efendi?SSlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:YanoJJlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:FOXJ FJFlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:HillertJJlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:MustafaMMlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:BakhietMMlld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:Abdel-HalimS...lld:pubmed
pubmed-article:9519762pubmed:authorpubmed-author:GuenifiAAlld:pubmed
pubmed-article:9519762pubmed:issnTypePrintlld:pubmed
pubmed-article:9519762pubmed:volume47lld:pubmed
pubmed-article:9519762pubmed:ownerNLMlld:pubmed
pubmed-article:9519762pubmed:authorsCompleteYlld:pubmed
pubmed-article:9519762pubmed:pagination498-504lld:pubmed
pubmed-article:9519762pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:meshHeadingpubmed-meshheading:9519762-...lld:pubmed
pubmed-article:9519762pubmed:year1998lld:pubmed
pubmed-article:9519762pubmed:articleTitleMutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes.lld:pubmed
pubmed-article:9519762pubmed:affiliationDepartment of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. samy.abdel-halim@molmed.ki.selld:pubmed
pubmed-article:9519762pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9519762pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9519762pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9519762pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9519762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9519762lld:pubmed